Bin Yu
Shaoxing University · 283 works · 8,175 citations · h-index 51
Top works
- Spirooxindoles: Promising scaffolds for anticancer agents
- Comparison between transrectal and transperineal prostate biopsy for detection of prostate cancer: a meta-analysis and trial sequential analysis
- Indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors in clinical trials for cancer immunotherapy
- Prediction of human absorption of natural compounds by the non-everted rat intestinal sac model
- Tetra-(tetraalkylammonium)octamolybdate catalysts for selective oxidation of sulfides to sulfoxides with hydrogen peroxide
- Discovery of orally active anticancer candidate CFI-400945 derived from biologically promising spirooxindoles: Success and challenges
- Synthesis and biological evaluation of novel steroidal[17,16-d][1,2,4]triazolo[1,5-a]pyrimidines
- The first Chinese oral anti-COVID-19 drug Azvudine launched
- Rational Molecular Editing: A New Paradigm in Drug Discovery
- A novel [1,2,4] triazolo [1,5-a] pyrimidine-based phenyl-linked steroid dimer: Synthesis and its cytotoxic activity
- Synthesis and biological evaluation of coumarin–1,2,3-triazole–dithiocarbamate hybrids as potent LSD1 inhibitors
- Advances Toward Lsd1 Inhibitors for Cancer Therapy
- FDA-approved pyrimidine-fused bicyclic heterocycles for cancer therapy: Synthesis and clinical application
- Natural Product-Derived Spirooxindole Fragments Serve as Privileged Substructures for Discovery of New Anticancer Agents
- Efficient synthesis of new antiproliferative steroidal hybrids using the molecular hybridization approach
- A Cell Membrane‐Targeting Self‐Delivery Chimeric Peptide for Enhanced Photodynamic Therapy and In Situ Therapeutic Feedback
- Novel insights into ferroptosis: Implications for age-related diseases
- Anti-inflammatory activities of triterpenoid saponins from Polygala japonica
- Design, synthesis and biological evaluation of [1,2,3]triazolo[4,5-d]pyrimidine derivatives possessing a hydrazone moiety as antiproliferative agents
- Double-edged roles of protein tyrosine phosphatase SHP2 in cancer and its inhibitors in clinical trials